You are here

Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Pfizer lines up an $830M alliance with Arvinas on protein degradation

Endpoints

Thu, 01/4/18 - 11:23 am

Tags:

Pfizer, Arvinas, targeted protein degradation, drug development

Pfizer defends kidney-cancer position with Bavencio 'breakthrough'

Fierce Pharma

Wed, 01/3/18 - 10:58 am

Tags:

Pfizer, kidney cancer, Bavencio, Merck KGaA

Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer

Marketwatch

Wed, 01/3/18 - 10:06 am

Tags:

Sangamo, Pfizer, ALS, gene therapy, drug development

Pfizer, Valneva stand to gain from Sanofi's C. diff vaccine flop: report

Fierce Pharma

Tue, 01/2/18 - 07:21 pm

Tags:

Pfizer, Valneva, Sanofi, C. difficile, vaccines, PF-06425090

Oncology business to keep leading pharma market in 2018

GoinPharma

Wed, 12/27/17 - 09:39 am

Tags:

oncology, Merck, Bristol-Myers Squibb, Pfizer, Roche

Merck, Pfizer make a late — very late — arrival at the SGLT2 party for diabetes

Endpoints

Thu, 12/21/17 - 10:07 am

Tags:

Merck, Pfizer, SGLT2 inhibitor, diabetes, tugliflozin

Array Biopharma ties up with Pfizer on cancer-fighting combos

Fierce Biotech

Wed, 12/20/17 - 09:51 am

Tags:

Array Biopharma, Pfizer, clinical trials, binimetinib, talazoparib, Merck KGaA, Bavencio, cancer

Pfizer, Exelixis cancer drugs get FDA approval for wider use

Reuters

Wed, 12/20/17 - 09:39 am

Tags:

Pfizer, Exelixis, Cabometyx, kidney cancer, Bosulif, blood cancer

A New PARP Drug For Breast Cancer

Forbes

Mon, 12/18/17 - 10:13 am

Tags:

PARP inhibitors, breast cancer, metastatic breast cancer, talazoparib, Pfizer

Here's Why GlycoMimetics Could Become a Takeover Target

Yahoo/Motley Fool

Sun, 12/17/17 - 10:22 am

Tags:

GlycoMimetics, M&A, GMI-1271, AML, acute myeloid leukemia, Pfizer

Pfizer takes on Novartis, Lilly with Xeljanz psoriatic arthritis approval

Fierce Pharma

Fri, 12/15/17 - 11:27 pm

Tags:

Pfizer, Novartis, Eli Lilly, Xeljanz, psoriatic arthritis

Pfizer Not Planning US Launch of its Second Remicade Biosimilar Approved by FDA

RAPS.org

Fri, 12/15/17 - 09:36 am

Tags:

Pfizer, biosimilars, Remicade, Ixifi, Inflectra, JNJ

Pfizer's second biosimilar of J&J's Remicade wins U.S. FDA approval

Yahoo/Reuters

Thu, 12/14/17 - 09:18 am

Tags:

Pfizer, biosimilars, JNJ, Remicade, Ifixi, rheumatoid arthritis, Crohn's Disease

Why 2017 Was a Year to Forget for Pfizer Inc.

Yahoo/Motley Fool

Wed, 12/13/17 - 09:39 am

Tags:

[forum discussion]Pfizer Jumps the Shark over Biosimilar Failure

Cafepharma Message Boards

Tue, 12/12/17 - 11:14 am

Tags:

Pfizer, biosimilars, Inflectra, Remicade, JNJ

Roche's Fight With Pfizer May Be Just The Beginning

Forbes

Mon, 12/11/17 - 11:31 pm

Tags:

Roche, Pfizer, Herceptin, biosimilars, cancer, Avastin, Rituxan

Men near the Viagra plant may be excited, but it’s not because of ‘love fumes,’ Pfizer says

Miami Herald, FL

Mon, 12/11/17 - 11:14 pm

Tags:

drug manufacturing, Ireland, Viagra, Pfizer

In a showdown with AstraZeneca, Pfizer posts solid — and very familiar — PhIII breast cancer data for talazoparib

Endpoints

Fri, 12/8/17 - 11:46 am

Tags:

Pfizer, AstraZeneca, talazoparib, advanced breast cancer, Lynparza, PARP inhibitors

Spark, Pfizer pass another milestone with impressive results treating hemophilia B

Endpoints

Thu, 12/7/17 - 09:14 am

Tags:

Spark Therapeutics, Pfizer, hemophilia B, SPK-9001

Pfizer Accuses J&J of Anticompetitive Business Practices over Remicade Biosimilar

JD Supra

Thu, 12/7/17 - 09:07 am

Tags:

Pfizer, JNJ, Remicade, biosimilars, anticompetitive practices, Celltrion

Pages

last 30 twitter posts